Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
22/01/2020 Medicinal Product Shortages - update - 22 January 2020 Advisory
20/01/2020 Implanon NXT - etonogestrel 68 mg, implant for subdermal use - Important Safety Information from MSD Ireland as approved by the HPRA 3rd Party Publications
17/01/2020 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3rd Party Publications
15/01/2020 Medicinal Product Shortages - update - 15 January 2020 Advisory
08/01/2020 Medicinal Product Shortages - update - 8 January 2020 Advisory
23/12/2019 Medicinal Product Shortages - update - 23 December 2019 Advisory
18/12/2019 Medicinal Product Shortages - update - 18 December 2019 Advisory
13/12/2019 HPRA MIMS Articles April 2019 3rd Party Publications
13/12/2019 HPRA MIMS Articles October 2018 3rd Party Publications
12/12/2019 INCRELEX (mecasermin) - Important Safety Information from Ipsen Pharmaceuticals Ltd as approved by the HPRA 3rd Party Publications